Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China.
Saved in:
| Title: | Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China. |
|---|---|
| Authors: | Akalu TY; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, WA, 6102, Australia. t.akalu@postgrad.curtin.edu.au.; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, WA, Australia. t.akalu@postgrad.curtin.edu.au.; Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. t.akalu@postgrad.curtin.edu.au., Clements ACA; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, WA, Australia.; Peninsula Medical School, University of Plymouth, Plymouth, UK., Gebreyohannes EA; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, WA, Australia.; School of Allied Health, University of Western Australia, Perth, WA, Australia., Xu Z; Xiangya School of Public Health, Central South University, Changsha, China., Bai L; TB Control Institute of Hunan Province, Changsha, China., Alene KA; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, WA, 6102, Australia.; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, WA, Australia.; Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. |
| Source: | BMC infectious diseases [BMC Infect Dis] 2024 Feb 02; Vol. 24 (1), pp. 159. Date of Electronic Publication: 2024 Feb 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
